C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2002
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	CN1385421A Novel alpha-amino acid compound, its preparation process and medicinal composition contaiing same
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495336 Oligopeptide derivatives for the electrochemical measurement of protease activity
12/12/2002	WO2002099379A2 Breast homing peptides and methods of identifying same using aminopeptidase p
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002	WO2002099045A2 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone
12/12/2002	WO2002098905A2 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
12/12/2002	WO2002059065A3 Oligo or polyalkylene glycol-coupled thrombin inhibitors
12/12/2002	WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures
12/12/2002	US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002	US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002	US20020187938 Ghrelin antagonists
12/12/2002	US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/11/2002	EP1264896A1 Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
12/11/2002	EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002	EP1263774A2 Gamma-secretase inhibitors
12/11/2002	EP1263473A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
12/11/2002	EP1263471A2 Antimicrobial compounds and formulations
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	CN1384823A Processes for preparation of oxo-oxazoline or alloamino acid derivatives
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492496 Antibodies to the receptor protein designated 2F1
12/10/2002	US6492491 Method of making hypusine peptides
12/10/2002	US6492490 Liquid phase peptide syntheses of KL-4 pulmonary surfactant
12/10/2002	US6492489 Synthetic hypusine peptides
12/10/2002	US6492421 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492335 Glycoconjugates from modified camptothecin derivatives (20-O-linkage)
12/10/2002	US6492118 Methods of immobilizing ligands on solid supports
12/10/2002	CA2086925C New salts derived from dialkylaminoalkysulphonyl-26 pristinamycin iib
12/10/2002	CA2070160C Method of preparing .alpha.-l-aspartyl-l-phenylalanine methyl ester
12/09/2002	WO2001096366A2 Dipeptide inhibitors for the blood-clotting factor xa
12/09/2002	CA2412181A1 Dipeptide inhibitors for the blood-clotting factor xa
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002096934A1 Non-natural galanin receptor ligands
12/05/2002	WO2002096933A1 2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives
12/05/2002	WO2002096930A2 Iap binding peptides and assays for identifying compounds that bind iap
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096892A1 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
12/05/2002	WO2002070018A3 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/05/2002	WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183369 For therapy of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis
12/05/2002	US20020183313 Cholecystokinin-A and B (CCK-A/B) antagonists and useful in therapy and prophylaxis of disorders of appetite regulatory systems (e.g., anorexia) disorders associated with intestinal smooth muscle hyperactivity (e.g., irritable bowel syndrome)
12/05/2002	US20020183260 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals
12/05/2002	US20020183255 Use of KPV tripeptide for dermatological disorders
12/05/2002	US20020183252 To inhibit tumor growth in an animal; to induce apoptosis
12/05/2002	US20020183249 Method of identifying inhibitors of CDC25
12/05/2002	US20020183243 Polyglutamic acid-camptothecin conjugates and methods of preparation
12/05/2002	US20020182147 Vitronectin receptor antagonist pharmaceuticals
12/05/2002	CA2449168A1 Iap binding peptides and assays for identifying compounds that bind iap
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2446282A1 2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives
12/05/2002	CA2411549A1 Ligands of integrin receptors
12/04/2002	EP1262558A1 Method of screening inducible nitric oxide synthase activation inhibitor
12/04/2002	EP1262479A1 Lactam-aldehyde compound and process of preparing same
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261742A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261637A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261634A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261633A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261624A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme
12/04/2002	EP1261623A1 New retinol derivatives, the method of preparations and the uses thereof
12/04/2002	EP1261619A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261618A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261380A1 Nucleic acids, proteins and antibodies
12/04/2002	EP1261362A2 Novel amino acid and peptide inhibitors of staphylococcus virulence
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0858262B1 Thrombin inhibitors
12/04/2002	EP0815124B1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/03/2002	WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489300 Inhibitors of adhesion in the treatment of inflammatory brain diseases and other inflammatory conditions
12/03/2002	CA2414000A1 Pyridin-2-ylaminoalkylcarbonylglycyl-beta-alanine and derivatives
12/03/2002	CA2254853C Compositions and methods for screening antimicrobials
11/2002
11/28/2002	WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094856A2 Gpe analogs and peptidomimetics
11/28/2002	WO2002094778A2 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
11/28/2002	WO2002094029A1 Method of inhibiting fungal growth
11/28/2002	WO2002080858A3 Use of kpv tripeptide for dermatological disorders
11/28/2002	US20020177725 Peptide inhibitors of hepatitis C virus NS3 protein
11/28/2002	US20020177557 Peptides and mimetics are based on the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABLO, Hid, Grim and Reaper, which interact with a specific surface groove of IAP.
11/28/2002	US20020177226 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	CA2448142A1 Beta-secretase substrates and uses thereof
11/27/2002	EP1260591A1 High-efficiency assay for protein mannosyl transferases

1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 307